Showing results 3 to 9 of 9
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
2014 | |||
Oncofetal Molecules as Biomarkers and Drug Targets for Hepatic Cancer Book:New Advances on Disease Biomarkers and Molecular Targets in Biomedicine | 2013 | ||
Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2 Journal:Digestive Diseases and Sciences | 2014 | ||
2017 | |||
Targeting Serine Peptidase Inhibitor, Kazal Type 1 (SPINK1) as a Potential Treatment for Hepatocellular Carcinoma Proceeding/Conference:Annual Conference of the International Liver Cancer Association, ILCA 2011 | 2011 | ||
The role of serine peptidase inhibitor, Kazal type I (SPINK1) in hepatocellular carcinoma Proceeding/Conference:Cancer Omics | 2010 | ||
Tumorigenic properties of serine peptidase inhibitor, Kazal type 1 (SPINK1) in hepatocellular carcinoma Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2011 | 2011 |